Beranda › Karsinoma Duktal In Situ (DCIS) › California
Uji klinis Karsinoma Duktal In Situ (DCIS) di California
7 studi untuk Karsinoma Duktal In Situ (DCIS) mencari peserta di lokasi di California.
Teks studi resmi (Bahasa Inggris)
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
- Berkeley Outpatient Center, Berkeley
- City of Hope -Duarte Cancer Center, Duarte
- City of Hope - Lennar Foundation Cancer Center, Irvine
- dan 4 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 28 Sep 2026 · NCT06075953Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- University of California Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California Davis, Sacramento
- dan 2 lainnya
Menerima pesertaSukarelawan sehat diterima
Usia 30 hingga 74 · Wanita · Diperbarui 21 Sep 2026 · NCT02620852Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
- City of Hope Comprehensive Cancer Center, Duarte
Menerima pesertaFase 2
Usia 35 ke atas · Wanita · Diperbarui 7 Jul 2026 · NCT05941520The PREDICT Registry:
- University of California San Diego, La Jolla
- Sutter Health, San Mateo
Menerima pesertaStudi observasional
Usia 30 hingga 85 · Wanita · Diperbarui 17 Apr 2026 · NCT03448926Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
- Stanford University, Stanford
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 12 Mar 2026 · NCT03909282Perioperative Mindfulness Proposal
- Hoag Memorial Hospital Presbyterian, Newport Beach
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 15 Okt 2024 · NCT04049214Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
- Office of Dennis R. Holmes, M.D., F.A.C.S., Glendale
Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 3 Mar 2023 · NCT05218044Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.